INOVIO PHARMACEUTICALS, INC. (INO) Reports Material Event to SEC
Filing Details INOVIO PHARMACEUTICALS, INC. (NASDAQ:INO) filed a Form 8-K with the Securities and Exchange Commission on July 31, 2026, disclosing a material event. Market Context…
Read more
